InvestorsHub Logo
Post# of 253153
Next 10
Followers 840
Posts 120462
Boards Moderated 18
Alias Born 09/05/2002

Re: DewDiligence post# 181521

Thursday, 08/28/2014 11:28:32 AM

Thursday, August 28, 2014 11:28:32 AM

Post# of 253153
MYL’s 40mg Copaxone ANDA has also been accepted by the FDA for review, according to a PR that just hit the wires:

http://finance.yahoo.com/news/mylans-anda-three-times-per-152000383.html

MYL claims it is eligible for shared first-to-file 180-day H-W exclusivity (implicitly acknowledging MNTA's PR).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.